Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions

Clinical trial NCT01224587 · COMPLETED

Trial details

NCT number: NCT01224587
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Magnetic Marker Monitoring Gastrointestinal-transport Gastric Emptying Time Small Intestinal Transit Time Time for Colon Arrival Food Effect

Start date: 2010-10-01
Primary completion: 2010-11-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.